Tags

Type your tag names separated by a space and hit enter

Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword.
Hum Gene Ther. 2021 07; 32(13-14):645-646.HG

Authors+Show Affiliations

Editor-in-Chief.Deputy Editor-in-Chief, Human Gene Therapy.

Pub Type(s)

News
Comment

Language

eng

PubMed ID

34283643

Citation

Flotte, Terence R., and Guangping Gao. "Immune Responses to Recombinant Adenoviruses as Gene Therapy Vectors and COVID-19 Vaccines: a Two-Edged Sword." Human Gene Therapy, vol. 32, no. 13-14, 2021, pp. 645-646.
Flotte TR, Gao G. Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword. Hum Gene Ther. 2021;32(13-14):645-646.
Flotte, T. R., & Gao, G. (2021). Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword. Human Gene Therapy, 32(13-14), 645-646. https://doi.org/10.1089/hum.2021.29169.trf
Flotte TR, Gao G. Immune Responses to Recombinant Adenoviruses as Gene Therapy Vectors and COVID-19 Vaccines: a Two-Edged Sword. Hum Gene Ther. 2021;32(13-14):645-646. PubMed PMID: 34283643.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword. AU - Flotte,Terence R, AU - Gao,Guangping, PY - 2021/7/20/entrez PY - 2021/7/21/pubmed PY - 2021/7/24/medline SP - 645 EP - 646 JF - Human gene therapy JO - Hum Gene Ther VL - 32 IS - 13-14 SN - 1557-7422 UR - https://www.unboundmedicine.com/medline/citation/34283643/Immune_Responses_to_Recombinant_Adenoviruses_As_Gene_Therapy_Vectors_and_COVID-19_Vaccines:_A_Two-Edged_Sword. DB - PRIME DP - Unbound Medicine ER -